Skip to content
Screener

Other product segments

Pet Health
$718M+11.7%
Cattle
$313M+16.8%
Poultry
$223M+3.7%
Contract Manufacturing
$17M+13.3%

Similar metrics at other companies

Zoetis logo
ZTSSwine — Revenue
$117M-0.8%
Orthofix Medical Inc. logo
OFIXGlobal Spine — Revenue
$173.24M+2.0%
Limoneira logo
LMNRSpecialty citrus and wine grapes — Revenue
$9K-98.7%
HRO
HROWOther Revenues — Revenue
$73K-15.1%
Oracle logo
ORCLCloud Revenues — Revenue
$9.91B+47.1%
Oracle logo
ORCLSoftware Revenues — Revenue
$6.82B-2.1%

Other financials

Income statement

See full
Revenue$1.4B+10.2%
Gross profit$798.0M+11.9%
Net income$54.0M+391%
EPS (diluted)$0.11+450%

Balance sheet

See full
Cash & equivalents$530.0M-1.7%
Total debt$4.2B-6.2%
Total equity$6.6B-2.8%
Total assets$13.6B-1.3%

Cash flow

See full
Operating cash flow$277.0M+16.9%
CapEx$33.0M-42.1%
Free cash flow$244.0M+35.6%

Valuation

See full
Market cap$13.1B+89.0%
Enterprise value$16.81B+54.0%
P/S2.6×+1.1×

Profitability

See full
Gross margin55.4%+0.6pp
Net margin-4%-13.8pp
FCF margin7.5%-0.5pp

Returns & leverage

See full
Return on equity-3%-9.9pp
Debt / equity0.6×0.0×
Current ratio2.1×-0.5×

Where this comes from

Reported directly by Elanco Animal Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Elanco Animal Health Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001739104-26-000043
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue$1,368$1,241$2,739$2,434
Cost of sales5705281,1561,037
Gross profit7987131,5831,397
Research and development9292189186
Marketing, selling and administrative449400830741
Amortization of intangible assets139136277264
Asset impairment, restructuring and other special charges912510
Interest expense, net of capitalized interest594811688

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Elanco Animal Health Inc.'s swine — revenue?
Elanco Animal Health Inc. (ELAN) reported swine — revenue of $97M in Q2 2026.
How has Elanco Animal Health Inc.'s swine — revenue changed year-over-year?
Elanco Animal Health Inc.'s swine — revenue decreased by 3.0% year-over-year, from $100M to $97M.
What is the long-term trend for Elanco Animal Health Inc.'s swine — revenue?
Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s swine — revenue has grown at a -4.9% compound annual growth rate (CAGR), from $464M to $379M.
What does swine — revenue mean?
This metric represents the total gross sales generated from the company's portfolio of products dedicated to the swine health market, including vaccines, parasiticides, and therapeutic treatments. It reflects the company's market penetration and commercial success within the global pork production industry. Fluctuations in this figure are often driven by changes in livestock population cycles, disease outbreaks, and the adoption of preventative health solutions by commercial producers.

Ask your AI about Elanco Animal Health Inc.'s swine — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude